BlackRock Fund Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $80K | Buy |
60,822
+2,150
| +4% | +$2.83K | ﹤0.01% | 3662 |
|
2016
Q3 | $123K | Buy |
58,672
+130
| +0.2% | +$273 | ﹤0.01% | 3582 |
|
2016
Q2 | $94K | Sell |
58,542
-877
| -1% | -$1.41K | ﹤0.01% | 3686 |
|
2016
Q1 | $58K | Sell |
59,419
-4,222
| -7% | -$4.12K | ﹤0.01% | 3773 |
|
2015
Q4 | $77K | Buy |
63,641
+3,402
| +6% | +$4.12K | ﹤0.01% | 3798 |
|
2015
Q3 | $448K | Sell |
60,239
-1,590
| -3% | -$11.8K | ﹤0.01% | 3251 |
|
2015
Q2 | $442K | Sell |
61,829
-630,636
| -91% | -$4.51M | ﹤0.01% | 3249 |
|
2015
Q1 | $5.95M | Buy |
692,465
+25,700
| +4% | +$221K | ﹤0.01% | 2745 |
|
2014
Q4 | $6.65M | Buy |
666,765
+111,867
| +20% | +$1.12M | ﹤0.01% | 2698 |
|
2014
Q3 | $5.49M | Sell |
554,898
-29,849
| -5% | -$295K | ﹤0.01% | 2694 |
|
2014
Q2 | $10.1M | Sell |
584,747
-63,583
| -10% | -$1.1M | ﹤0.01% | 2410 |
|
2014
Q1 | $11.5M | Buy |
648,330
+22,929
| +4% | +$407K | ﹤0.01% | 2317 |
|
2013
Q4 | $11.4M | Sell |
625,401
-23,619
| -4% | -$432K | ﹤0.01% | 2313 |
|
2013
Q3 | $17.4M | Buy |
649,020
+183,398
| +39% | +$4.92M | 0.01% | 2046 |
|
2013
Q2 | $8.59M | Buy |
+465,622
| New | +$8.59M | ﹤0.01% | 2345 |
|